Ajanta Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.70 M
as on 07-07-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.48 M
as on 07-07-2024
- Satisfied Charges ₹ 3.02 M
as on 07-07-2024
- Revenue 25.92%
(FY 2022)
- Profit -32.50%
(FY 2022)
- Ebitda -34.14%
(FY 2022)
- Net Worth 8.68%
(FY 2022)
- Total Assets 36.40%
(FY 2022)
About Ajanta Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹9.48 M. The company has closed loans amounting to ₹3.02 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Jain and Viralkumar Shah serve as directors at the Company.
- CIN/LLPIN
U24232GA1988PTC000924
- Company No.
000924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Bethora, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ajanta Medicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Jain  | Director | 04-Oct-2018 | Current |
| Viralkumar Shah | Director | 04-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Ajanta Medicals.
Ajanta Medicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.92% increase. The company also saw a substantial fall in profitability, with a 32.5% decrease in profit. The company's net worth moved up by a moderate rise of 8.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajanta Medicals?
In 2022, Ajanta Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Prime Limited Creation Date: 16 Mar 2011 | ₹2.00 M | Open |
State Bank Of India Creation Date: 09 Jan 2008 | ₹3.50 M | Open |
State Bank Of India Creation Date: 09 Nov 2006 | ₹1.63 M | Open |
How Many Employees Work at Ajanta Medicals?
Ajanta Medicals has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajanta Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
